Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

The effect of hemolysis, icterus and lipemia on Randox immunoturbidimetric adiponectin assay (CROSBI ID 241573)

Prilog u časopisu | Pismo uredniku

Pozaić, Petra ; Dukić, Lora ; Šimundić, Ana-Maria The effect of hemolysis, icterus and lipemia on Randox immunoturbidimetric adiponectin assay // Clinica chimica acta, 450 (2015), 64-66. doi: 10.1016/j.cca.2015.07.019

Podaci o odgovornosti

Pozaić, Petra ; Dukić, Lora ; Šimundić, Ana-Maria

engleski

The effect of hemolysis, icterus and lipemia on Randox immunoturbidimetric adiponectin assay

Adiponectin exhibits multiple roles in insulin resistance, inflamma-tory process, atherogenesis and cardioprotection. To evaluate analytical characteristics of the Randox immunoturbidimetric adiponectinassay (Randox Laboratories Limited, Crumlin, UK), not otherwise pro-vided by the manufacturer reagent insert sheet, we have explored: i) method precision ; ii) comparability of adiponectin concentration inserum as recommended sample by the manufacturer and lithium–heparin plasma and iii) influence of hemolysis, lipemia and icterus onadiponectin concentration according to CLSI EP7-A2 protocol forinterference testing in clinical chemistry. The effect of hemolysis, icterus and lipemia on Randox immunoturbidimetric adiponectin assay.

Hemolysis ; Icterus ; Lipemia ; Adiponectin assay

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

450

2015.

64-66

objavljeno

0009-8981

10.1016/j.cca.2015.07.019

Povezanost rada

Kliničke medicinske znanosti, Farmacija

Poveznice
Indeksiranost